HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mark Clayer Selected Research
Mark Clayer Research Topics
Disease
3
Osteosarcoma (Osteogenic Sarcoma)
04/2015 - 06/2002
3
Neoplasms (Cancer)
07/2008 - 06/2002
1
Bursitis (Adhesive Capsulitis)
11/2014
1
Arthritis (Polyarthritis)
11/2014
1
Infections
11/2010
1
Chondrosarcoma
09/2009
1
Aneurysmal Bone Cysts
05/2008
1
Melanoma (Melanoma, Malignant)
08/2002
1
Breast Neoplasms (Breast Cancer)
08/2002
Drug/Important Bio-Agent (IBA)
1
Antirheumatic Agents (DMARD)
IBA
11/2014
1
Calcium Sulfate (Alabaster)
IBA
05/2008
1
Messenger RNA (mRNA)
IBA
08/2002
1
Ephrin-B3 (Ephrin B3)
IBA
08/2002
1
Ligands
IBA
08/2002
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
08/2002
1
Proteins (Proteins, Gene)
FDA Link
08/2002
1
Ephrin-A5 (AL-1)
IBA
08/2002
1
Ephrin-B1 (Ephrin B1)
IBA
08/2002
1
Ephrin-B2 (Ephrin B2)
IBA
08/2002
1
EphA1 Receptor (Eph Receptor)
IBA
08/2002
1
Ephrins
IBA
08/2002
1
Ephrin-A1 (Ephrin A1)
IBA
08/2002
1
Ephrin-A3 (Ephrin A3)
IBA
08/2002
1
Ephrin-A4 (Ephrin A4)
IBA
08/2002
1
Cytokines
IBA
06/2002
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
06/2002
Therapy/Procedure
1
Neoadjuvant Therapy
04/2015
1
Reoperation
11/2010
1
Surgical Amputation (Amputations)
09/2009
1
Limb Salvage
07/2008
1
Injections
05/2008
1
Therapeutics
06/2002
1
Drug Therapy (Chemotherapy)
06/2002